Skip to main content
SpringerLink
Log in

Schizophrenie

Therapievorteile mit partiellen Dopamin-D2-Rezeptoragonisten

  • infopharm
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Satellitensymposien „Dopamine D2 partial agonists in the treatment of schizophrenia — finding the right balance“, 31. ECNP-Kongress in Barcelona, 8.10.2018; Veranstalter: Lundbeck und Otsuka

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Abdol A. Ameri (freier Medizinjournalist)

Authors
  1. Abdol A. Ameri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ameri, A.A. Therapievorteile mit partiellen Dopamin-D2-Rezeptoragonisten. InFo Neurologie 20, 46–47 (2018). https://doi.org/10.1007/s15005-018-2844-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-018-2844-y

Search

Navigation